HER-2 Protein Vaccine in Treating Women With Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: HER-2/neu peptide vaccine
Sponsor: Case Comprehensive Cancer Center
Collaborators: National Cancer Institute (NCI)